Labiotech.eu

Reporting on innovations in global biotech.

[Labiotech.eu @Labiotech_eu]

Find out what the eight most expensive drugs in the world currently are, as several gene therapies top the list. https://t.co/Vc3RO17YpX

[Labiotech.eu @Labiotech_eu]

Biotech and biopharma companies choose names that cluster around certain letters in the alphabet - here's what they are, and why it happens. https://t.co/rhNdo6jsZt

[Labiotech.eu @Labiotech_eu]

This week we preview the BIO International Convention, starting next week in San Diego. This is the key partnering event of the year where biotechs connect with pharmaceutical companies and investors in partnering meetings, all to advance and fund innovative therapies. ...

[Labiotech.eu @Labiotech_eu]

We have curated a list of in vivo CAR T biotechs in preclinical and clinical stages that you should keep an eye out for.  https://t.co/HR3fyv9exV

[Labiotech.eu @Labiotech_eu]

This is a test https://t.co/ZKTW1rnH0a

[Labiotech.eu @Labiotech_eu]

Explore how viral vector CDMOs improve late-stage cell and gene therapy success by reducing risk, variability, and complexity. https://t.co/t8Qptw6cgq

[Labiotech.eu @Labiotech_eu]

Find out more about the wave of biotech rebranding and why a growing number of companies are choosing this path to start afresh. https://t.co/LzuT46F6x6

[Labiotech.eu @Labiotech_eu]

Not so long ago, DIY biology mostly meant extracting DNA from strawberries or growing mold in a petri dish for a school science project. Those experiments are still around, but the world of amateur biology has evolved considerably over the past decade. 

Today, a growing ne...

[Labiotech.eu @Labiotech_eu]

Today we’re diving into the world of corticosteroids and hormonal therapies, essential APIs that treat everything from asthma and autoimmune diseases to diabetes and endocrine disorders. https://t.co/JM7TFEIPe8

[Labiotech.eu @Labiotech_eu]

Discover Daiichi Sankyo's pipeline strategy, including how it aims to become a top-five global oncology company by 2035. https://t.co/UNiXmozYk7

[Labiotech.eu @Labiotech_eu]

Find out about some early-stage technologies in neurology that aim to go beyond amyloid, dopamine, and what has dominated the field. https://t.co/Wrkdwj6Yfv

[Labiotech.eu @Labiotech_eu]

Spain is emerging as a European pharma and biotech hub, driven by scientific excellence, clinical trial leadership, innovation, and investor appeal. https://t.co/L2P9FZm2Xc

[Labiotech.eu @Labiotech_eu]

There were seven multibillion-dollar acquisitions that occurred in May 2026, although it was a quieter month on the biotech deals front. https://t.co/EToPjX691t

[Labiotech.eu @Labiotech_eu]

Today we are delighted to welcome back a very special guest: Joachim Eeckhout, the co-founder of Labiotech, co-owner of Knowbio, and founder of The Science Marketer. https://t.co/ig2jExjgsO

[Labiotech.eu @Labiotech_eu]

Labiotech heard from experts about the major trends and highlights in cancer care at ASCO 2026. https://t.co/jgNuZDw6Ut

[Labiotech.eu @Labiotech_eu]

We look at how rising acquisitions in the life science industry are being driven by patent cliffs.  https://t.co/YXt9YUKHcz

[Labiotech.eu @Labiotech_eu]

Explore the future of cell and gene therapies in China as it adopts a new piece of regulation that might change strategies. https://t.co/X0Re7x2Bij

[Labiotech.eu @Labiotech_eu]

Find out about how biotech companies are trying to address the limits the first generation of WEE1 inhibitors faced. https://t.co/EPiUN2Of7U

[Labiotech.eu @Labiotech_eu]

Today we welcome Dr. Daniel Vitt, CEO of Immunic Therapeutics. With World MS Day tomorrow 30th of May, this is the perfect moment to focus on multiple sclerosis. https://t.co/rEFG4g54aw

[Labiotech.eu @Labiotech_eu]

Discover how Lab Thread unifies fragmented life science data into one platform to streamline workflows, collaboration, and research. https://t.co/1uwj3ggx0d